The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @agargmd: Read carefully: coronary artery disease STILL progresses on $14,000 per year drug. For that price, it should heal lepers, rest…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @Drlipid: Of interest: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is…

RT @Drlipid: Of interest: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is…

Read carefully: coronary artery disease STILL progresses on $14,000 per year drug. For that price, it should heal lepers, restore eyesight and make you walk on water. It doesn’t. #plantbased diet regresses plaque, known for over 30 years: Pritikin, Ornish,

@Drlipid let’s discuss during our marathon session in August. https://t.co/jL65eYrBdI

RT @Drlipid: Of interest: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @Drlipid: Of interest: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is…

Of interest: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy Open access at https://t.co/0rSs6HvKjK @nationallipid

RT @PeterAttiaMD: But I'm not sure I know what this means. Calcium is a marker for disease, but most studies suggest that once you're on a…

But I'm not sure I know what this means. Calcium is a marker for disease, but most studies suggest that once you're on a statin, further calc is a good, not bad, thing. So does this mean PCSK9i are helping or hurting that process? https://t.co/4Hzc5u7EE3

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

RT @drjkahn: PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@…

PCSK9 inhibitors slow coronary artery calcium. Great news for statin intolerant or ineffective patients. ⁦⁦@nationallipid⁩ ⁦@lipiddoc⁩ ⁦@cardio10s⁩ ⁦@ACCinTouch⁩ ⁦@AmHeartAdvocacy⁩ ⁦@CLEHeartLab⁩ ⁦@EricTopol⁩ https://t.co/nPWpIi1PMI

RT @Nature_NPJ: Coronary artery calcification: entry to new frontier of PCSK9 inhibitors https://t.co/zNkHwjkqO1 #aging #heartdisease ht…

Coronary artery calcification: entry to new frontier of PCSK9 inhibitors https://t.co/zNkHwjkqO1 #aging #heartdisease https://t.co/4lrXphSIxV

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy https://t.co/dG0i8Wnc5y https://t.co/4GX5UUInf6